NCT05071846 2026-04-14
MVX-ONCO-2 in Advanced Solid Tumors
University Hospital, Geneva
Phase 1 Active not recruiting
Clinical Trials
5 trialsNCT05763004 2026-03-27
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
ImmunOs Therapeutics AG
Phase 1 Active not recruiting
NCT04221204 2026-03-25
A Monotherapy in Subjects With Advanced Solid Tumors
3D Medicines
Phase 1 Active not recruiting
NCT06265688 2026-03-25
First In Human Study of CX-2051 in Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Recruiting
NCT06462794 2026-03-24
First In Human Study of CX-801 in Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Recruiting